AI assistant
GILEAD SCIENCES, INC. — Director's Dealing 2013
Nov 8, 2013
29828_dirs_2013-11-08_bd62c7b1-3fcd-464a-bb68-4dac78ec7700.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2013-11-06
Reporting Person: Washington Robin L (SVP, CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-11-06 | Common Stock | S | 1669 | $68.2174 | Disposed | 24026 | Direct |
| 2013-11-06 | Common Stock | S | 1100 | $69.1682 | Disposed | 22926 | Direct |
| 2013-11-06 | Common Stock | S | 100 | $69.70 | Disposed | 22826 | Direct |
Footnotes
F1: The sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
F2: Sale prices reported for the transactions reported here range from $67.65 to $68.55. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F3: Sale prices reported for the transactions reported here range from $68.66 to $69.50. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.